Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Germany Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20023
20034
20043
20056
200610
20075
20085
20097
20108
20116
20128
20135
20147
201513
20162
20178
20185
20198
20208
20219
20229
20232
20247
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99
Terminated23
Recruiting16
Active, not recruiting16
Unknown status8
Withdrawn2
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company16
Novartis Pharmaceuticals14
Bristol-Myers Squibb9
European Organisation for Research and Treatment of Cancer - EORTC7
Hoffmann-La Roche7
AstraZeneca6
Pfizer6
Bayer5
GlaxoSmithKline5
AIO-Studien-gGmbH4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung167
Lung Neoplasms35
Neoplasms11
Melanoma10
Neoplasm Metastasis7
Breast Neoplasms5
Pancreatic Neoplasms5
Colorectal Neoplasms4
Head and Neck Neoplasms4
Adenocarcinoma of Lung3

Trials

Showing 1 to 25 of 167. Each trial links to its page on Pharma Observatory.

67 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.